Valeo Health raises $12 million Series B for expansion

We are thrilled by the strong investor support as we continue to redefine how people engage with their health. This funding enables us to scale our AI technology, enhance our product offerings, and expand our reach, ensuring more individuals benefit from proactive healthcare solutions.

This investment validates our team's hard work and strengthens our ability to scale personalised healthcare across the region.

We first backed Valeo in 2021, drawn by the strength of the founding team and a clear opportunity to address a real market need. Since then, Sundeep, Nadine and Ankur have delivered with focus and consistency, building an integrated platform with strong cross-border potential and impressive year-over-year growth. A key to their success has been providing customers with real benefits across multiple touchpoints and associated journeys. With this round, we have the opportunity to deepen the customer centricity and provide even more value to our most important stakeholder. We're excited to continue supporting Valeo as they scale and take the business to the next stage.